Charles & Colvard Reports Third Quarter 2009 Financial Results

* Reuters is not responsible for the content in this press release.

Thu Nov 12, 2009 4:01pm EST

http://www.businesswire.com/news/home/20091112006079/en

* 62% increase in net sales over second quarter 2009
* $6.8 million in cash and no long-term debt at end of quarter
* Positive cash flow from operations; $1.4 million generated through the first
nine months of 2009

MORRISVILLE, N.C.--(Business Wire)--
Charles & Colvard, Ltd. (NASDAQ: CTHR), the sole manufacturer of moissanite
jewels, The Most Brilliant Jewel in the WorldTM, announced today its financial
results for the third quarter ended September 30, 2009. 

Net sales for the quarter were $2.1 million, down 48% from $4.2 million in the
third quarter of 2008. Net sales for the first nine months of 2009 were $6.0
million, down 47% from $11.2 million for the same period of 2008. Sales were
impacted by the economic recession, which has measurably affected the retail and
jewelry industries, combined with reduced demand from major retailers who curbed
purchases due to current levels of moissanite inventory. However, net sales for
the quarter were up 62% over net sales of $1.3 million in the second quarter of
2009 compared to a 14% increase in third quarter 2008 over second quarter 2008. 

Loss from operations for the quarter was $491,000, a $4.4 million, or 90%,
improvement over the loss from operations of $4.9 million in the third quarter
of 2008. Loss from operations for the first nine months of 2009 was $2.9
million, a $4.6 million, or 61%, improvement over the loss from operations of
$7.6 million for the same period of 2008. Offsetting sales declines was a
reduction in costs and expenses in the three and nine months ended September 30,
2009 of $6.4 million and $9.9 million, respectively, when compared with the
corresponding periods in 2008, due to lower sales and cost control measures,
including a reduction in headcount and decreased expenses for sales and
marketing programs, and a bad debt charge of $4.1 million recorded in third
quarter 2008. 

Randy N. McCullough, Chief Executive Officer of Charles & Colvard, commented,
"My first week on the job has been quite pleasing with the third quarter results
generated by the team. Seasonally, sales in this quarter are generally strong;
however, we experienced a larger increase than projections that were based on
prior months` trends. The team also continued identifying cost savings which,
when combined with our improved sales, resulted in the lowest quarterly net loss
we have recorded since third quarter 2007. My first priority as Charles &
Colvard's new Chief Executive Officer will be to work closely with our customers
and the management team to leverage our strengths, thus creating new
opportunities for moissanite in the marketplace. We believe our jewel has great
potential as we reposition its future." 

Financial Position

The Company had $6.8 million in cash at the end of the quarter and generated
$1.4 million of cash from operations during the nine months ended September 30,
2009. A $1.5 million decrease in accounts receivable, receipt of a $2.1 million
income tax receivable, and a $2.2 million decrease in inventory were the primary
drivers for positive cash flow, which more than offset the net loss of $3.0
million and a $1.3 million decrease in accounts payable. 

Total inventory, including long-term and consignment inventory, was $42.2
million at the end of the quarter, down slightly from $43.0 million at year-end
2008 and at the end of second quarter 2009. No purchases of raw material were
made in the nine months ended September 30, 2009. Trade accounts receivable were
$918,000, down from $3.8 million at year-end 2008 and up from $363,000 at the
end of second quarter 2009. Cash collections and a settlement agreement with a
former customer positively impacted accounts receivable during the first nine
months of 2009. 

NASDAQ Listing Status

In August 2008, the Company was notified by the Listing Qualifications
Department of The NASDAQ Stock Market LLC ("NASDAQ") that its common stock is
subject to potential delisting from the NASDAQ Global Select Market because, for
the preceding 30 consecutive business days, the price of the Company`s common
stock had closed below the minimum $1.00 closing bid price requirement. In
response to extraordinary market conditions, NASDAQ suspended enforcement of the
minimum $1.00 closing bid requirement until July 31, 2009. As a result of the
temporary suspension, the Company currently has until December 2, 2009 to regain
compliance with the minimum $1.00 closing bid price requirement for continued
listing on the NASDAQ Global Select Market. 

Third Quarter Results Webcast

Charles and Colvard will host a webcast to present third quarter 2009 results on
Thursday, November 12, 2009 at 4:15 p.m. Eastern Time. The webcast can be
accessed live and will be available for replay at www.charlesandcolvard.com. 

About Charles & Colvard, Ltd.

Charles & Colvard, Ltd. (NASDAQ: CTHR), based in the Research Triangle Park area
of North Carolina, is the global sole source of lab-created moissanite, a
unique, near-colorless jewel that is distinct from other gemstones and jewels
based on its exceptional fire, brilliance, luster, durability, and rarity.
Charles & Colvard Created Moissanite is currently used in fine jewelry sold
primarily through domestic and international retailers. For more information,
please access www.moissanite.com or www.charlesandcolvard.com. 

Charles & Colvard and Charles & Colvard Created Moissanite are registered
trademarks of Charles & Colvard, Ltd. 

This press release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, or the Securities Act,
and Section 21E of the Securities Exchange Act of 1934, as amended, or the
Exchange Act. Statements expressing expectations regarding our future and
projections relating to products, sales, revenues, and earnings are typical of
such statements and are made under the Private Securities Litigation Reform Act
of 1995. These forward-looking statements include, but are not limited to,
statements about our plans, objectives, representations, and contentions and are
not historical facts and typically are identified by use of terms such as "may,"
"will," "should," "could," "expect," "plan," "anticipate," "believe,"
"estimate," "predict," "continue," and similar words, although some
forward-looking statements are expressed differently.

All forward-looking statements are subject to the risks and uncertainties
inherent in predicting the future. You should be aware that although the
forward-looking statements included herein represent management`s current
judgment and expectations, our actual results may differ materially from those
projected, stated, or implied in these forward-looking statements as a result of
many factors including, but not limited to, the recent downturn in the worldwide
economy and its ongoing impact on our business and the business of our customers
and suppliers, any continued trends in the general economy that would adversely
affect consumer spending, a further decline in our sales, dependence on consumer
acceptance of our products, dependence on Cree, Inc. as the current supplier of
most of the raw material, ability to develop a material second source of supply,
dependence on a limited number of customers, risks of conducting operations in
foreign countries, dependence on third parties for the sales and marketing of
our products to end consumers, continued listing of our common stock on the
NASDAQ Global Select Market, and the impact of significant changes in our
management on our ability to execute our business strategy in the near-term, in
addition to the other risks and uncertainties described in more detail in our
filings with the Securities and Exchange Commission, or the SEC, including our
Annual Report on Form 10-K for the fiscal year ended December 31, 2008 and
subsequent reports filed with the SEC. Forward-looking statements speak only as
of the date they are made. We undertake no obligation to update or revise such
statements to reflect new circumstances or unanticipated events as they occur
except as required by the federal securities laws, and you are urged to review
and consider disclosures that we make in the reports that we file with the SEC
that discuss other factors relevant to our business.

 Charles & Colvard, Ltd.                                                                                                                                                                                              
 
Condensed Consolidated Statements of Operations                                                                                                                                                                     
 
(unaudited)                                                                                                                                                                                                         
                                                                                                                                                                                                                 
                                                                                       Three Months Ended                                                Nine Months Ended                                       
                                                                                       
September 30,                                                    
September 30,                                          
                                                                                       2009                           2008                            2009                           2008                  
 Net sales                                                                             $     2,145,003               $     4,162,544                $     5,950,398               $     11,206,104     
 Costs and expenses:                                                                                                                                                                                   
 Cost of goods sold                                                                          848,936                       1,519,997                      2,580,899                     4,227,588      
 Sales and marketing                                                                         673,917                       2,006,745                      1,504,308                     5,821,681      
 General and administrative                                                                  1,082,000                     5,480,036                      4,411,042                     8,686,837      
 Research and development                                                                    31,084                        12,461                         376,775                       35,640         
 Total costs and expenses                                                                    2,635,937                     9,019,239                      8,873,024                     18,771,746     
 Loss from operations                                                                        (490,934    )                 (4,856,695)                    (2,922,626  )                 (7,565,642  )  
 Interest income                                                                             6,746                         21,495                         25,594                        96,218         
 Loss before income taxes                                                                    (484,188    )                 (4,835,200   )                 (2,897,032  )                 (7,469,424  )  
 Income tax benefit (expense)                                                                (17,270     )                 1,712,587                      (62,187     )                 2,570,236      
 Net loss                                                                              $     (501,458    )           $     (3,122,613   )           $     (2,959,219  )           $     (4,899,188  )  
                                                                                                                                                                                                       
 Net loss per common share:                                                                                                                                                                            
 Basic and fully diluted                                                               $     (0.03       )           $     (0.17        )           $     (0.16       )           $     (0.27       )  
 Weighted average number of shares used in computing net loss per common share:                                                                                                                        
 Basic and fully diluted                                                                     18,925,224                    18,334,136                     18,638,453                    18,209,532     
                                                                                                                                                                                                       


 Charles & Colvard, Ltd.                                                                                                    
 
Condensed Consolidated Balance Sheets                                                                                     
                                                                                                                        
                                                                September 30,                  December 31,             
                                                                2009                           2008                     
                                                                
(unaudited)                                            
 ASSETS                                                                                                               
 Current assets:                                                                                                      
 Cash and cash equivalents                                      $        6,795,215            $        5,587,144      
 Accounts receivable, net                                                918,473                       3,754,657      
 Interest receivable                                                     60                            2,747          
 Income tax receivable                                                   -                             2,074,420      
 Notes receivable                                                        -                             142,000        
 Inventory, net                                                          2,297,863                     6,849,239      
 Inventory on consignment, net                                           672,127                       1,442,608      
 Prepaid expenses and other assets                                       292,077                       500,643        
 Deferred income taxes                                                   1,484,140                     1,231,071      
 Total current assets                                                    12,459,955                    21,584,529     
 Property and equipment, net                                             339,160                       412,234        
 Patent and license rights, net                                          268,081                       279,315        
 Inventory, non-current, net                                             39,241,461                    34,727,841     
 Note receivable, non-current                                            224,627                       82,627         
 Deferred income taxes, non-current                                      575,075                       940,903        
 TOTAL ASSETS                                                   $        53,108,359           $        58,027,449     
                                                                                                                      
 LIABILITIES AND STOCKHOLDERS` EQUITY                                                                                 
 Current liabilities:                                                                                                 
 Accounts payable                                               $        315,530              $        1,631,074      
 Deferred revenue                                                        -                             171,181        
 Accrued co-op advertising                                               308,965                       401,849        
 Accrued expenses and other liabilities                                  200,171                       623,584        
 Total current liabilities                                               824,666                       2,827,688      
 Long-term liabilities:                                                                                               
 Accrued income taxes                                                    3,214,218                     3,154,110      
 Total liabilities                                                       4,038,884                     5,981,798      
 Commitments and contingencies                                                                                        
 Stockholders` equity:                                                                                                
 Common stock, no par value                                              52,910,075                    52,910,075     
 Additional paid-in capital - share-based compensation                   6,160,289                     6,177,246      
 Accumulated deficit                                                     (10,000,889  )                (7,041,670  )  
 Total stockholders` equity                                              49,069,475                    52,045,651     
 TOTAL LIABILITIES AND STOCKHOLDERS` EQUITY                     $        53,108,359           $        58,027,449     
                                                                                                                      


 Charles & Colvard, Ltd.                                                                                                                                          
 
Condensed Consolidated Statements of Cash Flows                                                                                                                 
 
(unaudited)                                                                                                                                                     
                                                                                                                                                                 
                                                                                            Nine Months Ended September 30,                                      
                                                                                            2009                                     2008                       
 CASH FLOWS FROM OPERATING ACTIVITIES:                                                                                                                      
 Net loss                                                                                   $        (2,959,219  )                 $        (4,899,188  )   
 Adjustments to reconcile net loss to net cash provided by (used in) operating activities:                                                                  
 Depreciation and amortization                                                                       126,418                                159,756         
 Share-based compensation                                                                            93,520                                 333,983         
 Provision for uncollectible accounts                                                                166,600                                4,540,000       
 Provision for sales returns                                                                         (135,000    )                          125,000         
 Consignment inventory reserve                                                                       (153,000    )                          324,000         
 Provision (benefit) for deferred income taxes                                                       112,759                                (1,785,494  )   
 Loss on disposal of assets                                                                          -                                      62,135          
 Changes in assets and liabilities:                                                                                                                         
 Accounts receivable                                                                                 1,530,344                              1,445,091       
 Income tax receivable                                                                               2,074,420                              (596,637    )   
 Inventory                                                                                           2,235,477                              (663,913    )   
 Other assets, net                                                                                   211,253                                272,077         
 Accounts payable                                                                                    (1,315,544  )                          (2,507,210  )   
 Deferred revenue                                                                                    (171,181    )                          100,000         
 Accrued co-op advertising                                                                           (92,884     )                          218,208         
 Other accrued liabilities, net                                                                      (363,305    )                          257,801         
 Net cash provided by (used in) operating activities                                                 1,360,658                              (2,614,391  )   
                                                                                                                                                            
 CASH FLOWS FROM INVESTING ACTIVITIES:                                                                                                                      
 Purchases of property and equipment                                                                 (20,044     )                          (28,910     )   
 Patent and license rights costs                                                                     (22,066     )                          (268,751    )   
 Proceeds from sale of equipment                                                                     -                                      898             
 Net cash used in investing activities                                                               (42,110     )                          (296,763    )   
                                                                                                                                                            
 CASH FLOWS FROM FINANCING ACTIVITIES:                                                                                                                      
 Excess tax cost from share-based payment arrangements                                               (110,477    )                          -               
 Net cash used in financing activities                                                               (110,477    )                          -               
                                                                                                                                                            
 Effect of foreign currency translations                                                             -                                      1,263           
                                                                                                                                                            
 NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS                                                1,208,071                              (2,909,891  )   
 CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD                                                      5,587,144                              7,048,409       
 CASH AND CASH EQUIVALENTS, END OF PERIOD                                                   $        6,795,215                     $        4,138,518       
 Supplemental schedule of non-cash operating activities:                                                                                                    
 Inventory acquired from settlement of accounts receivable                                  $        1,274,240                     $        -               
 Supplemental schedule of non-cash investing activities:                                                                                                    
 Reduction of note receivable                                                               $        -                             $        140,763         


Charles & Colvard, Ltd.
Timothy Krist, Chief Financial Officer
919-468-0399, ext. 295
tkrist@charlesandcolvard.com
or
Investor Relations:
Fran Barsky, 919-244-7357
fbarsky@charlesandcolvard.com



Copyright Business Wire 2009

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.